Squarepoint
JBIO

Squarepoint’s Jade Biosciences JBIO Stock Holding History

Squarepoint’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$627K Buy
+44,650
New +$647K ﹤0.01% 3157
2025
Q1 		– Sell
-559
Closed -$51.8K – 4564
2024
Q4 		$51.8K Buy
+559
New +$48.2K ﹤0.01% 4838
2024
Q3 		– Sell
-1,631
Closed -$94.8K – 4101
2024
Q2 		$94.8K Buy
+1,631
New +$1.08M ﹤0.01% 3813
2023
Q4 		– Sell
-504
Closed -$239K – 3999
2023
Q3 		$239K Buy
+504
New +$273K ﹤0.01% 3304
2022
Q1 		– Sell
-370
Closed -$153K – 2809
2021
Q4 		$153K Buy
+370
New +$187K ﹤0.01% 2805
2021
Q3 		– Sell
-257
Closed -$205K – 2897
2021
Q2 		$205K Buy
+257
New +$205K ﹤0.01% 2811

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return